Exogenus Therapeutics Overview

  • Founded
  • 2015
  • Status
  • Out of Business
  • Employees
  • 3
  • Latest Deal Type
  • Out of Business

Exogenus Therapeutics General Information


Developer of an exosome-based platform technology designed to offer an innovative pipeline of therapeutic products. The company's platform leverages the strong regenerative, anti-inflammatory and immunomodulatory properties of proprietary vesicles, enabling healthcare providers to access a pipeline of products for skin and autoimmune diseases.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Other Industries
Other Pharmaceuticals and Biotechnology
Drug Discovery
Primary Office
  • Biocant Park Center 04
  • Lote 2
  • Cantanhede, 3060-197
  • Portugal
+351 231 000 000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Exogenus Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Out of Business 01-Oct-2019 00000 Completed Out of Business
5. Grant 17-Oct-2016 000.00 00000 Completed Startup
4. Early Stage VC 10-Dec-2015 00000 00000 Completed Startup
3. Grant 000.00 00000 Completed Startup
2. Accelerator/Incubator 01-Jan-2015 $123K $123K Completed Startup
1. Accelerator/Incubator Completed Startup
To view Exogenus Therapeutics’s complete valuation and funding history, request access »

Exogenus Therapeutics Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial